AH
Highly rated in
18
conditions

Dr. Allen C. Ho

Wills Eye Hospital
Philadelphia, PA
Highly rated in
18
conditions
Specialties:Ophthalmology
Experience:35 Years
Clinical Trials:Currently Recruiting for 1 Trial
Accepts:New PatientsMedicare
Highly rated in
18
conditions
About|Expertise|Insurance|Location|Research
Areas of Expertise

Many doctors have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions a doctor treats and their level of experience.

Check Dr. Allen C. Ho's experience treating your condition:
About Dr. Allen C. Ho

Allen Ho is an Ophthalmologist in Philadelphia, Pennsylvania. Ho has been practicing medicine for over 35 years and is highly rated in 18 conditions, according to our data. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Retinal Vein Occlusion, Cataract Removal, and Corneal Transplant. He is licensed to treat patients in New Jersey and Pennsylvania. Ho is currently accepting new patients.

His clinical research consists of co-authoring 234 peer reviewed articles and participating in 11 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Allen C. Ho it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Allen C. Ho accepts the following insurance:

  •  Ambetter
Call to see if your plan is accepted.
Locations
840 Walnut St, Suite 1020, Philadelphia, PA 19107
Other Locations
10 Presidential Blvd., Suite 200, Bala Cynwyd, PA 19004
Background & Education
Graduate Institution
Columbia University College Of Physicians And Surgeons, 1988
Specialties
Ophthalmology
Licenses
Ophthalmology in NJ
Hospital Affiliations
Redeemer Health
Bryn Mawr Hospital
Thomas Jefferson University Hospital
Wills Eye Hospital
Chestnut Hill Hospital
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

11 Clinical Trials
Active Surveillance of Papillary Thyroid Microcarcinoma
Enrollment Status: Recruiting
Publish Date: July 07, 2022
Intervention Type: Other
Study Phase: Not Applicable
Phase I/IIa Dose Escalation Safety and Efficacy Study of Human Embryonic Stem Cell-Derived Retinal Pigment Epithelium Cells Transplanted Subretinally in Patients With Advanced Dry-Form Age-Related Macular Degeneration (Geographic Atrophy)
Enrollment Status: Completed
Publish Date: November 04, 2022
Intervention Type: Biological
Study Drug: OpRegen
Study Phase: Phase 1/Phase 2
New Enrollment Post-Approval Study of the Argus® II Retinal Prosthesis System
Enrollment Status: Terminated
Publish Date: December 23, 2021
A Double-Masked, Randomized, Sham-Controlled, Parallel Group, Multi-Center Study to Assess the Safety and Efficacy of Photobiomodulation (PBM) in Subjects With Dry Age-Related Macular Degeneration (AMD) (LIGHTSITE III)
Enrollment Status: Active, not recruiting
Publish Date: February 05, 2021
Intervention Type: Device
Study Phase: Not Applicable
Intravitreal Dexamethasone Implant for Persistent Macular Thickening and Edema After Vitrectomy for Epiretinal Membrane: A Pilot Study
Enrollment Status: Terminated
Publish Date: October 03, 2018
Intervention Type: Drug
Study Phase: Not Applicable
Inflammasomes in Cell Death in Macular Hole, Epiretinal Membrane, and Rhegmatogenous Retinal Detachment
Enrollment Status: Completed
Publish Date: August 17, 2018
Intervention Type: Procedure
Comparative Analysis of Three-dimensional Heads-up Display Surgical Platform to Standard Operating Microscope for Vitreoretinal Surgery
Enrollment Status: Completed
Publish Date: August 17, 2018
Intervention Type: Device
Intravitreal Aflibercept Injection for Persistent Central Serous Chorioretinopathy: A Prospective Pilot Study
Enrollment Status: Completed
Publish Date: June 16, 2017
Intervention Type: Drug
Study Phase: Phase 2
Dexamethasone Implant With Rescue Ranibizumab for Treating Macular Edema Secondary to Retinal Vein Occlusion
Enrollment Status: Unknown status
Publish Date: February 20, 2015
Intervention Type: Drug
Study Phase: Not Applicable
Short Term Ocular Safety Assessment of High Dose Omega-3 Supplementation for Age-Related Macular Degeneration.
Enrollment Status: Completed
Publish Date: November 22, 2011
Intervention Type: Other, Dietary Supplement
Study Phase: Not Applicable
A Multicenter, Randomized, Single-masked Study Comparing Reduced-fluence Visudyne®-Lucentis® Combination Therapies and Lucentis® Monotherapy in Subjects With Choroidal Neovascularization (CNV) Secondary to AMD.
Enrollment Status: Completed
Publish Date: June 02, 2011
Intervention Type: Drug
Study Phase: Phase 2
View 10 Less Clinical Trials -
233 Total Publications
REFRACTIVE ERROR CHANGE DURING TREATMENT OF DIABETIC MACULAR EDEMA: A Post Hoc Analysis of the Diabetic Retinopathy Clinical Research Protocol T Trial.
Journal: Retina (Philadelphia, Pa.)
Published: October 21, 2022
Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
CS
Carol L. Shields
Dr. Carol L. Shields
Ophthalmology
Highly rated in
47
conditions
Ophthalmology

Wills Eye Hospital

840 Walnut St, 
Philadelphia, PA 

Carol Shields is an Ophthalmologist in Philadelphia, Pennsylvania. Shields has been practicing medicine for over 40 years and is highly rated in 47 conditions, according to our data. Her top areas of expertise are Melanoma of the Eye, Retinoblastoma, Coats Disease, Cataract Removal, and Tissue Biopsy. She is licensed to treat patients in Pennsylvania. Shields is currently accepting new patients.

TA
Dr. Tomas S. Aleman
Ophthalmology
Highly rated in
20
conditions
Ophthalmology

Penn Medicine

Penn Presbyterian Medical Center

51 N 39th St, 
Philadelphia, PA 
 2.4 mi

Tomas Aleman is an Ophthalmologist in Philadelphia, Pennsylvania. Aleman has been practicing medicine for over 35 years and is highly rated in 20 conditions, according to our data. His top areas of expertise are Choroideremia, Leber Congenital Amaurosis, Cone Dystrophy, and Retinitis Pigmentosa. He is licensed to treat patients in Pennsylvania. Aleman is currently accepting new patients.

BL
Dr. Bart P. Leroy
Ophthalmology
Highly rated in
21
conditions
Ophthalmology

34th & Civic Center Blvd, 
Philadelphia, PA 
 2.1 mi

Bart Leroy is an Ophthalmologist in Philadelphia, Pennsylvania. Leroy has been practicing medicine for over 31 years and is highly rated in 21 conditions, according to our data. His top areas of expertise are Leber Congenital Amaurosis, Late-Onset Retinal Degeneration, Retinitis Pigmentosa, Retinopathy Pigmentary Mental Retardation, and Cataract Removal. He is licensed to treat patients in Pennsylvania. Leroy is currently accepting new patients.